The United Kingdom became the first western country to pass the Covid-19 vaccine, ahead of the United States and Europe after the Medical and Health Products Control Agency (MHRA) passed the Pfizer-BioNTech vaccine today, after proving it was safe for use.
According to spokespersons from the UK's Office of Health and Social Care in fact, the vaccine will reportedly be available for vaccination starting next week, when the elderly and health care workers will primarily receive the vaccine.
Pfizer previously announced that the analysis of the vaccine developed in conjunction with BioNTech shows that it is effective as much as 95% without causing any health problems.
Pfizer Chair and Chief Executive Officer, Albert Bourla said this first graduation was a "historic moment" and praised the MHRA for their ability to carry out rigorous assessments and take appropriate action in time to protect the British people.
In July, Pfizer and BioNTech announced an agreement with the UK to include 30 million doses of mRNA-based vaccine, once justified for anxiety use.
The agreement was later increased to 40 million dos in early October. Thus, the UK will have sufficient dosages to vaccinate about one-third of its 66 million population.
